非酒精性脂肪肝疾病作为2型糖尿病患者心血管疾病的潜在危险因素:一项前性队列研究
Mohammad Dehghani Firouzabadi1, Amirhossein Poopak1, Ali Sheikhy1,2
1Endocrinology and Metabolism Research Center (EMRC) Vali-Asr Hospital Tehran University of Medical Sciences, Tehran, Iran.
非酒精性脂肪肝 (NAFLD) 在2型糖尿病 (T2D) 患者中显著增加心血管疾病 (CVD) 风险. 然而,肝酶水平在这个队列中与心血管疾病发病率没有显著的关联.
科学领域:
- 心脏病学 心脏病学
- 肝病学 肝病学是一种肝病学.
- 内分泌学 在内分泌学.
背景情况:
- 非酒精性脂肪性肝病 (NAFLD) 是2型糖尿病 (T2D) 中常见的并发症.
- 越来越多地认为NAFLD是心血管疾病 (CVD) 的风险因素.
研究的目的:
- 调查NAFLD与T2D患者心血管疾病发病率之间的关联.
- 评估肝酶和阿斯巴达胺转移酶与血小板比率指数 (APRI) 在预测该人群中心血管疾病风险方面的作用.
主要方法:
- 一项前性队列研究涉及1197名T2D患者,分为NAFLD (360) 和非NAFLD (847) 组.
- 随访时间中位数为5年,以记录心血管疾病发病率.
- 考克斯回归分析以评估NAFLD,肝酶,APRI和心血管疾病风险之间的关联.
主要成果:
- NAFLD与心血管疾病发病率的增加显著相关 (HR=1.488,p=0.029).
- 患有NAFLD的患者表现出更高的ALT和AST水平 (p<0.001).
- 在调整了变量后,没有发现肝酶 (ALT,AST) 和心血管疾病发病率之间的显著关联. NAFLD与较高的APRI四分位数存在关联.
结论:
- NAFLD是T2D患者心血管疾病发病率增加的独立风险因素.
- 标准肝酶 (ALT,AST,ALK-P,GGT) 在调整为混因子时,与T2D患者的心血管疾病风险没有显著关联.
更多相关视频
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
08:41Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
相关概念视频
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes: Symptoms, Diagnosis, and Complications
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Psychoneuroimmunology: Diabetes and Cancer
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Obesity
